CANnabiDiol for CoviD-19 pATiEnts With Mild to Moderate Symptoms

NCT04467918 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

SARS-CoV2

Interventions

DRUG: Cannabidiol
OTHER: PLACEBO

Sponsor

University of Sao Paulo

Collaborators

[object Object]
[object Object]